BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2944152)

  • 1. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
    Mellerup ET; Plenge P
    Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]citalopram binding to brain and platelet membranes of human and rat.
    Plenge P; Mellerup ET
    J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
    Hrdina PD; Foy B; Hepner A; Summers RJ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
    Plenge P; Mellerup ET; Honoré T; Honoré PL
    J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.
    Rosel P; Menchon JM; Oros M; Vallejo J; Cortadellas T; Arranz B; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(1):89-96. PubMed ID: 9085196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.
    Plenge P; Mellerup ET
    Biochim Biophys Acta; 1984 Feb; 770(1):22-8. PubMed ID: 6230106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MAO activity, 3H-imipramine binding, 3H-paroxetine binding and 3H-5-HT uptake by human cerebrospinal fluid.
    Egashira T; Goto S; Murayama F; Yamanaka Y
    J Neural Transm Suppl; 1990; 32():447-56. PubMed ID: 2150970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-dark differences in [3H]-paroxetine binding to rabbit platelet membranes.
    Rocca P; Galzin AM; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):41-4. PubMed ID: 2529443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
    Raisman R; Cash R; Agid Y
    Neurology; 1986 Apr; 36(4):556-60. PubMed ID: 2938025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of [3H]paroxetine binding to rat cortical membranes.
    Habert E; Graham D; Tahraoui L; Claustre Y; Langer SZ
    Eur J Pharmacol; 1985 Nov; 118(1-2):107-14. PubMed ID: 2935409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat.
    Moret C; Briley M
    Psychiatry Res; 1991 Aug; 38(2):97-104. PubMed ID: 1836639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.